CD26low (n=29) CD26high (n=29) p
Age (years) 61.90 ± 8.703 59.03 ± 9.104 0.226
Sex Males 20 (69.0) 20 (69.0) 1.000
Females 9 (31.0) 9 (31.0)
Lymphadenopathy 27 (93.1) 28 (96.6) 1.000
Splengomegaly 15 (51.7) 23 (79.3) 0.027
Hepatomegaly 13 (44.8) 18 (62.1) 0.188
Binet stage A (n=24) 13 (44.8) 8 (27.6) 0.251
B (n=13) 7 (24.1) 6 (20.7)
C (n=24) 9 (31.0) 15 (51.7)
Rai stage 0+I (n=17) 10 (34.5) 7 (24.1) 0.546
II (n=15) 8 (27.6) 7 (24.1)
III+IV (n=26) 11 (37.9) 15 (51.7)
Total leucocytic count (X109/l) 53.40 ± 59.24 97.61 ± 91.10 0.033
Hemoglobin concentration (g/dl) 11.35 ± 2.33 10.31 ± 2.56 0.111
Platelet count (X109/l) 198.03 ± 77.23 160.48 ± 56.98 0.040
Peripheral blood mature lymphocytic count (x109) 45.31 ± 53.32 78.98 ± 86.68 0.081
LDH (u/l) 518.24 ± 134.50 738.66 ± 275.38 <0.001
CD38low 24 (82.8) 2 (6.9) <0.001
CD38high 5 (17.2) 27 (93.1)
ZAP70low 25 (86.2) 0 (0) <0.001
ZAP70high 4 (13.8) 29 (100.0)
LDH: Lactate Dehydrogenase. Age, total leucocytic count, hemoglobin concentration, platelet count, peripheral blood mature lymphocytic count, LDH are presented by mean ± SD. Sex, lymphadenopathy, splenomegaly, hepatomegaly, Binet and Rai stages, CD38high, ZAP70high are presented by number and percentages
Table 1: Relationship between CD26 expression and other prognostic parameters.